Rethinking clinical trials in the multimorbidity era: the imperative for patient-centered tailored approaches

Area of Science:

• Clinical Trials
• Gerontology
• Public Health

Background:

• Multimorbidity affects 40% of adults, over half of those over 60.
• Traditional trial designs are inadequate for multimorbidity's complexity.
• Existing research gaps limit generalizability and applicability of findings.

Purpose of the Study:

• Review current trial designs for multimorbidity.
• Identify limitations in existing research.
• Advocate for innovative, patient-centered approaches.

Main Methods:

• Commentary based on an international workshop.
• Analysis of current limitations in multimorbidity trials.
• Proposal of new methodologies and reporting guidelines.

Main Results:

• Need for holistic and integrative experimental approaches.
• Advocacy for adaptive trial designs and subgroup analyses.
• Emphasis on patient-reported outcomes and ethical considerations.

Conclusions:

• Bridge the gap between multimorbidity research and clinical practice.
• Foster development of effective interventions.
• Improve patient outcomes and quality of care for those with multimorbidity.